Filer Snapshot

CANTEX PHARMACEUTICALS, INC.

CIK 0001374961. SEC filing timeline plus parsed ownership intelligence from 13F, 13D/G, and Forms 3/4/5 where available.

Entity Type

Company

Total Filings

11

Latest Filing

03 Feb 2022

Industry

Pharmaceutical Preparations

Filing-backed research brief

Start with the SEC data that changes for this CIK

Latest signal: Forms 3/4/5 owner position for CMRX. Each card links back to the PortfolioSavvy page where the filing evidence is closest.

Open owner activity Save page

Largest parsed holding

—

Populates from the latest parsed 13F information table.

Open holding

13D/G large stake

—

No recent parsed 13D/G stake row for this CIK.

Browse 13D/G

Save this filer page

Create a free account to keep this page in your watchlists. After verification, we will save it automatically and open your saved research list.

Create free account and save this filer Already have an account? Sign in and save it
Source: SEC Schedule 13D/G

SC 13G/A filed on 03 Feb 2022 for CIK 0001374961.

View Source Filing
Identity
Industry
Pharmaceutical Preparations (Office Of Life Sciences)
Business address
1792 Bell Tower Lane, Suite 222, Weston, FL, 33326
SEC ownership signals
Filing-backed coverage

Insider holdings value

$3.34M

Parsed Forms 3/4/5 holdings where value can be estimated.

Top ownership positions
CMRX
SEC record
State of incorporation
DE
Fiscal year end
31 December
Former names
PARINGENIX INC (to 31 Oct 2013)

Filer intelligence

What SEC filings say about CANTEX PHARMACEUTICALS, INC.

A compact read of parsed XML filings. 13F, 13D/G, and Forms 3/4/5 are shown separately because they answer different ownership questions.

Save filer

Quick read

  • Forms 3/4/5 show insider context for CMRX worth $3.34M.

SEC source mix

Counts show available parsed rows, not one combined ownership total.

XML parsed
13F portfolio No rows yet

Quarterly institutional portfolio holdings.

Open
13D/G stakes No rows yet

Beneficial ownership and large-stake disclosures.

Open
Forms 3/4/5 1 rows

Officer, director, and 10% owner holdings or transactions.

Open

Forms 3/4/5 insider context

CMRX

14 Sep 2021 · 10% owner

$3.34M
Issuer page Owner page

Latest update

What changed recently for CANTEX PHARMACEUTICALS, INC.

Ownership report updated

Latest ownership report period: 14 Sep 2021. Open the source-backed page to inspect the fresh filing or facts context.

Update date

16 Sep 2021

Page type

Ownership filings

Latest period

14 Sep 2021

Ownership context was refreshed from SEC Forms 3/4/5 filed on 16 Sep 2021.

Open ownership filings Browse recent public updates

Benchmark Context

Benchmark context for this company

CANTEX PHARMACEUTICALS, INC. has a source-backed company facts view where you can compare the latest reported metrics with its own recent history and with peer rankings for the same metric.

Compared with

Start on the facts page for period-to-period context, then open a metric ranking when you want to compare the same reported fact across other SEC-reporting companies.

Why this is notable

Latest ownership report period: 14 Sep 2021. That gives you a fresh baseline before you compare this company with peers.

  • Peer comparisons stay conservative: same metric, compatible units, latest valid company row only.
  • Open the facts page first if you want the cleanest path to verification.

Benchmark context is only shown where the app has enough comparable SEC-backed data to keep the interpretation honest.

Open company facts Browse metric rankings

SEC filing record

CIK 0001374961 filing coverage

Start with this filing record, then use the linked ownership pages when parsed 13F, 13D/G, Forms 3/4/5, or facts data exists for this CIK.

SEC filings
11
First seen
05 Sep 2006
Latest filing
03 Feb 2022
Entity
Company

Observed form types

SC 13G/A 4 3/A SC 13G 3 D/A D REGDEX

Primary evidence

Open SEC filing index CANTEX PHARMACEUTICALS, INC. SEC filings CANTEX PHARMACEUTICALS, INC. owner filings

Industry context: Pharmaceutical Preparations.

Latest Filings

Showing the latest 9 of 9 SEC filings for CANTEX PHARMACEUTICALS, INC..

SC 13G/A

SC 13G/A

Filing date
03 Feb 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4 File 001-35867

FORM 4 SUBMISSION

Filing date
16 Sep 2021
Reporting date
14 Sep 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
3/A File 001-35867

FORM 3/A SUBMISSION

Filing date
07 Aug 2019
Reporting date
29 Jul 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G

SC 13G

Filing date
06 Aug 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
3 File 001-35867

FORM 3 SUBMISSION

Filing date
06 Aug 2019
Reporting date
26 Jul 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
D/A File 021-192030

D/A filing

Filing date
23 Apr 2014
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
D/A File 021-192030

D/A filing

Filing date
31 Oct 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
D File 021-192030

D filing

Filing date
19 Feb 2013
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
D File 021-145926

D filing

Filing date
04 Aug 2010
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .